Canton Strategic Holdings (CNTN) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 55 176 sessions, February 18, 2026 to October 28, 2026
- Largest daily move
- -17.5% close of June 24, 2026
- 1-month change
- -24.2% closing prices, September 28, 2026 to October 28, 2026
Company Description
Canton Strategic Holdings, Inc. (NASDAQ: CNTN) is an operating company focused on Canton Coin, Canton Network infrastructure and clinical-stage biotechnology research and development. The company describes itself as the first publicly traded company to leverage Canton Coin to support the Canton Network's role in digitizing traditional financial markets. Its digital asset strategy centers on Canton Coin acquisition, operation of a Super Validator, participation in network governance and investment in applications that support Canton Network utilization.
The Canton Network is a privacy-enabled blockchain architecture used for institutional financial-market activity. Canton Strategic Holdings participates in that ecosystem through validator operations that support transaction validation and network operations. The company also maintains a Canton-focused digital asset treasury strategy and has arranged regulated custody and operational controls for its digital asset holdings, including cold storage and multi-signature wallet infrastructure.
Digital asset and network activities
The company's Canton Network activities are built around Canton Coin, validator infrastructure and applications intended to expand network use by institutional market participants. Canton Strategic Holdings also participates in Canton Foundation governance. The Canton Foundation is described in company materials as the independent governance body responsible for the operation, standards and validator framework of the Canton Network, including policies related to the Global Synchronizer and broader network operations.
Canton Strategic Holdings established its digital asset strategy through a completed private placement in 2025. Its public disclosures describe this strategy as including Canton Coin acquisition, Super Validator operations, investments in applications that support network utilization and governance participation through the Canton Foundation.
Biotechnology research and development
In addition to its digital asset activities, Canton Strategic Holdings operates a clinical-stage biotechnology research and development arm. The biotech business includes GV104, identified as a flagship clinical asset being developed for respiratory and/or nervous system depression in military personnel and chemical incident responders. The pipeline also includes other potential GV104 indications, GV023 for autoimmune disease approaches and an early-stage multispecific biologic platform.
Canton Strategic Holdings is listed on Nasdaq under the symbol CNTN. Its principal executive offices are in Red Bank, New Jersey.
Stock Performance
Canton Strategic Holdings (CNTN) closed at $2.04 on October 28, 2026. Over the past month, the price has lost 24.2%.
CNTN Metrics & Rankings
Price returns through October 28, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
Canton Strategic Holdings has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 4 with negative movement. Key topics include earnings, management, buybacks. View all CNTN news →
SEC Filings
Canton Strategic Holdings has filed 10 recent SEC filings, including 8 Form 4, 1 Form SCHEDULE 13G, 1 Form 8-K. The most recent filing was submitted on October 27, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all CNTN SEC filings →
Financial Highlights
operating income reached -$20.1M, and net income was -$35.9M. Diluted earnings per share stood at -$1.12. The company generated -$16.1M in operating cash flow. The current ratio was 5.29, measuring current assets divided by current liabilities.
Upcoming Events
Short Interest History
Short interest in Canton Strategic Holdings (CNTN) currently stands at 7.8 million shares, up 15.4% from the previous reporting period, representing 11.4% of the float. Since February 2026, short interest has increased by 168.9%.
Days to Cover History
Days to cover for Canton Strategic Holdings (CNTN) currently stands at 7.1 days, down 39.7% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Since February 2026, the figure has increased by 63.1%. Across the settlements charted above, it has ranged from 3.6 to 13.8 days.
CNTN Company Profile & Sector Positioning
Canton Strategic Holdings (CNTN) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NASDAQ.